Bausch Health Companies INC Form 4 insider transactions

Director Brett Icahn acquired 5,119 common shares of Bausch Health Companies Inc. in lieu of cash compensation for board service.

Director John Paulson acquired 9,659 common shares of Bausch Health Companies Inc. on March 31, 2025, in lieu of cash compensation for board service.

John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., reports changes in beneficial ownership due to tax withholding obligations upon vesting of Restricted Share Units.

Bausch Health Companies Inc. CEO Thomas Appio disposed of shares to cover tax withholding obligations upon the vesting of Restricted Share Units on February 28, 2025.

Seana Carson, EVP and General Counsel of Bausch Health Companies Inc., reported disposing of common shares to cover tax withholding obligations upon the vesting of Restricted Share Units.

John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., reports the acquisition of restricted share units and a decrease in holdings of common shares.

EVP Aimee J. Lenar reports acquisition of restricted share units and disposal of common shares of Bausch Health Companies Inc.

Seana Carson, EVP and General Counsel of Bausch Health Companies Inc., reports the acquisition of restricted share units.

EVP and CFO of Bausch Health Companies Inc., Jean-Jacques Charhon, reports acquisition and disposal of common shares and restricted share units.

Bausch Health Companies Inc. CEO Thomas Appio was granted 635,425 restricted share units (RSUs) on February 26, 2025, according to a recent SEC filing.

Bausch Health director Amy B. Wechsler acquired 852 common shares through restricted stock units in lieu of cash compensation.

Director John Paulson acquired 7,754 shares of Bausch Health through restricted stock units in lieu of cash compensation.

Brett Icahn, a director at Bausch Health Companies Inc., acquired 4,109 common shares through restricted stock units as part of his board compensation.

Bausch Health's EVP, General Counsel, Seana Carson, sold 440 shares of common stock at $8.35 per share, following a tax withholding transaction of 1,692 shares at $8.37 per share.

Director Amy Wechsler acquired 842 common shares of Bausch Health Companies Inc. on September 30, 2024, as compensation for board service.

Brett Icahn, a director at Bausch Health Companies Inc., acquired 4,059 common shares in lieu of cash compensation for board service.

Director John Paulson acquired 7,659 common shares of Bausch Health Companies Inc. on September 30, 2024, in lieu of cash compensation for board service.

Seana Carson, EVP and General Counsel of Bausch Health Companies Inc., reports disposition of shares to cover tax obligations and sales under a pre-arranged Rule 10b5-1 plan.

John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., sold 3,982 common shares to cover tax withholding obligations.

CEO Thomas Appio disposed of 14,683 common shares of Bausch Health Companies Inc. to satisfy tax withholding obligations upon the vesting of Restricted Share Units.

EVP and CFO of Bausch Health Companies Inc., Jean-Jacques Charhon, received an award of 298,838 restricted share units on August 19, 2024.

John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., reports the acquisition of restricted share units.

EVP of US Pharma at Bausch Health Companies Inc., Aimee J. Lenar, reports acquiring 144,352 common shares through restricted share units.

Director Amy Wechsler acquired 986 common shares of Bausch Health Companies Inc. as compensation for board service.

Brett Icahn, a director at Bausch Health Companies Inc., acquired 4,752 common shares in lieu of cash compensation for board service.

Director John Paulson acquired 8,967 shares of Bausch Health Companies Inc. in lieu of cash compensation for board service.

John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., disposed of 1,930 common shares to cover tax withholding obligations upon vesting of Restricted Share Units.

John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., received 39,126 restricted share units (RSUs) on February 29, 2024, according to a Form 4/A filing with the SEC.

Thomas Appio, CEO of Bausch Health Companies Inc., files an amended SEC Form 4/A to correct the vesting schedule of restricted share units (RSUs) previously reported.

Richard Mulligan, a director of Bausch Health Companies Inc., filed an amended Form 4 to clarify a previous filing regarding beneficial ownership of common shares.